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Abstract
Coronary computed tomography angiography (CCTA) is used extensively nowa‐
days as a non-invasive imaging method for the evaluation of patients suspected of
coronary artery disease, providing data on calcium burden, the presence of coro‐
nary artery stenoses, but also, more recently, on coronary atherosclerotic plaque
morphology and composition. Plaque morphology analysis by CCTA aims to accu‐
rately identify vulnerable plaques, in an attempt to reduce the number of ischemic
events triggered by high-risk atherosclerotic lesions. Recent research provides
CCTA descriptions of vulnerable plaques and a particular radiological sign shows
promising perspectives. The napkin-ring sign refers to a rupture-prone plaque in a
coronary artery, comprising a necrotic core covered by a thin cap fibro-atheroma.
The napkin-ring sign is described on CCTA in cross-sectional images of coronary
arteries as a central low-attenuation area surrounded by an open ring area of high
attenuation, having a high specificity and positive predictive value for the presence
of advanced lesions. These lesions have been designated as vulnerable plaques, in‐
dicating an increased probability of rupture, and were shown to correlate with a
higher incidence of cardiovascular events. In acute coronary syndromes, the loca‐
tion of the napkin-ring sign was shown to correspond to the culprit lesions. The aim
of the current paper is to provide an overview of the current literature on available
methods for quantitative measurement of atherosclerotic plaque features from
CCTA and to discuss the clinical implications of the napkin-ring sign as detected by
CCTA.
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1. Introduction
The development of atherosclerosis by lipoprotein storage, inflammation, muscle cell prolif‐
eration, necrosis, apoptosis, calcification, and fibrosis in the arterial wall triggers important
changes in the coronary vessels, leading to coronary artery disease (CAD). In fact, atheroscle‐
rosis is the main etiology of CAD, and plaque rupture followed by intraluminal thrombosis is
the most common cause of acute coronary events, including sudden coronary death [1, 2]. For
that reason, the early and accurate characterization and quantification of atherosclerotic
plaques is valuable for preventing and managing acute coronary syndrome (ACS) [3]. In
everyday clinical practice, major acute ischemic cardiac events involve plaque rupture in thin-
cap fibroatheromas, which are considered vulnerable plaques; these rupture-prone athero‐
sclerotic lesions usually contain a high level of lipids and have a large necrotic core, numerous
inflammatory cells, and a thin, vulnerable fibrotic cap [4]. Vulnerable atherosclerotic plaques
can be characterized by several invasive and non-invasive methods that are either fully
validated, pending validation, or still under scrutiny for clinical practice. Among non-invasive
methods, coronary computed tomography angiography (CCTA) by multi-detector computed
tomography (MDCT) is currently the preferred modality for evaluating the extent of CAD,
providing the advantage of accurate assessment of coronary atherosclerotic plaque morphol‐
ogy and composition. In two recent multicenter trials [5, 6], CCTA was shown to have excellent
sensitivity (95–99%) and negative predictive value (97–99%), although rather low specificity
(64–83%) for identifying patients with at least one coronary artery stenosis among individuals
at low to intermediate risk for CAD. Moreover, CCTA imaging of atherosclerotic plaques was
found to correlate well with invasive assessment by intravascular ultrasound (IVUS) [7, 8, 9].
2. Role of MDCT in the detection of plaque morphology and composition
2.1. Plaque characteristics
2.1.1. Plaque morphology and composition
Pathophysiologically, a subendothelial accumulation of lipoproteins generates inflammatory
responses involving macrophages and T-cells, leading to the further development of athero‐
sclerotic lesions [10]. Initially, atherosclerotic lesions were classified as fatty streaks, fibroa‐
theromas [11], and advanced plaques, complicated with hemorrhage, calcification, ulceration,
and thrombosis [12]. Over the years, this classification became more complex and six types of
atherosclerotic lesions have been defined by the American Heart Association (AHA) Consen‐
sus Group: type I - characterized by adaptive intimal thickening; type II - fatty streak; type III
- transitional or intermediate lesions; type IV - advanced plaques (atheromas); type V -
fibroatheroma or atheroma with thick fibrous cap; and type VI - complicated plaques with
denudated surface, and/or hematoma/hemorrhage, and/or thrombosis [13]. The earliest lesions
are represented by adaptive intimal thickening (AHA type I) and fatty streaks or intimal
xanthoma, which are basically foam cell collections (AHA type II) [13]. AHA type III transi‐
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tional lesions, described as pathological intimal thickening, represent the earliest stage of the
progressive plaques and are considered precursor lesions of more advanced fibroatheroma.
This type of lesions consists of multiple layers of proliferating smooth muscle cells near the
lumen, with an increased quantity of lipids on the intimal medial border. Intimal xanthomas
are lesions containing a large amount of foamy macrophages but without lipid acumulation
outside the cell [14]. Type IV AHA, also called fibrous cap atheromas, are the first of the
advanced lesions of coronary atherosclerosis [15] and are characterized by the presence of a
necrotic core with a high amount of lipids surrounded by a fibrous cap containing smooth
muscle cells, collagen, and proteoglicans, as well as inflammatory cells such as macrophages
and lymphocytes. This type of lesion can cause significant artery stenosis and may be submit‐
ted to complications, namely surface disruption, thrombosis, and calcification. Fibrous cap
plaques may be more or less prone to complications depending on the thickness of the cap:
fibroatheromas are more stable due to the rather thick fibrous cap, while thin-cap fibroather‐
omas characterize the typycal "vulnerable plaques" [15].
In fact, thin-cap fibroatheromas are very likely to lead to plaque rupture. Although they are
not included as individual entities in the AHA consensus classification, plaque erosion and
calcified nodules are also prone to coronary thrombosis. Erosions may occur on intimal
thickening or fibroatheroma, whereas the notion of calcified nodules refers to eruptive
fragments of calcium that protrude into the lumen, causing a thrombotic event [16]. Also,
plaque ruptures may heal by wide accumulation of proteoglycans, having more reduced
necrotic cores and more extensive areas of calcification. In their study on early coronary lesion
progression near branch points, Nakashima et al. provided evidence endorsing the hypothesis
that intimal thickening lesions with macrophages are more advanced [17].
Macrophage infiltration in lipid pools rich in cholesterol and the deterioration of the extrac‐
ellular matrix believed to be induced by matrix metalloproteinase activity suggest early stages
of the necrosis process and should be recognized. This particular feature, combined with
macrophage destruction as a consequence of an anomalous phagocytic clearance of apoptotic
cells, may contribute to the development of late plaque necrosis. In addition to that, an
extended necrotic core is a strong predictor of complications [17, 18].
Thin-cap fibroatheromas are highly prone to plaque rupture due to their rather large necrotic
core and thin, inflamed fibrous cap (<65 µm). The accumulation of an increased number of
macrophages at the level of the cap is characteristic, although exceptions may occur. However,
as a significant number of fatal coronary events are triggered by plaque rupture due to the
impairment of the fibrous cap followed by thrombosis, early recognition of thin-cap fibroa‐
theromas is crucial. The fibrous cap mainly contains type I collagen, variable numbers of
macrophages and lymphocytes, and rather few alpha-actin positive smooth muscle cells.
Fibrous cap disruption exposes the lipid-rich necrotic core, favoring the formation of local
thrombi by platelet accumulation. Most plaque ruptures are reported in the proximal segments
of the coronary arteries, near branch points, with the left anterior descending coronary artery
being the most frequently affected, followed by the right and left circumflex coronary arteries
[19]. Although the mechanisms behind plaque rupture are far from being fully understood,
the increased activity of matrix metalloproteinases, excessive enzyme secretion by inflamma‐
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tory cells, high shear stress, macrophage calcification, and iron build-up are recognized as
implicated factors. Data are also beginning to pool on different gene expression in stable and
unstable atherosclerotic plaques [20]. For instance, in one study, differential expression of 18
genes coding for metalloproteinase ADAMDEC1, retinoic acid receptor responser-1, cysteine
protease legumain (a potential activator of matrix metalloproteinases), and cathepsins was
shown to contribute to increased lesion vulnerability [20]. As previously mentioned, the
extension of the necrotic core is also a main factor in plaque complication development, and
intraplaque hemorrhage was shown to favor the accumulation of free cholesterol provided by
red blood cells in these lesions [21]. As atherosclerotic lesions expand, more vasa vasorum
infiltrate the plaque and become leaky, triggering intraplaque hemorrhage [22]. Morphologic
studies have suggested that repeated ruptures are responsible for plaque progression beyond
40–50% cross-sectional luminal stenoses [23]. Three hystological types of lesions have been
described in association with acute coronary events: rupture, erosion, and calcified nodule [13].
Ruptured coronary atherosclerotic plaques folowed by intraluminal thrombosis are the most
common cause of acute myocardial infarction [24]. In fact, two-thirds of luminal thrombi in
acute events result from ruptured atherosclerotic lesions characterized by a necrotic core
covered by a thin layer of fibrous cap [4]. Ruptured plaques are characterized by a lipid-rich
necrotic core (>40% of the total volume of the plaque), surrounded by a thin, fibrous cap with
active inflammation (increased number of monocytes, macrophages, and sometimes even T-
cells), endothelial denudation leading to superficial platelet aggregation, and the presence of
hemodynamically significant coronary artery stenosis (>90%) [19]. Vulnerable plaques prone
to rupture share most of the morphological characteristics with ruptured plaques, showing a
large necrotic core, macrophage infiltration, and often an increased number of intraplaque
vasa vasorum [4], but an intact, thin fibrous cap [13]. These lesions—called thin-cap fibroa‐
theromas—are considered to be at high risk for rupture and subsequent ischemic events [4].
The destruction of the endothelium exposes the minimally inflammed intima containing
smooth muscle cells and proteoglycans to circulating platelets, favoring thrombus formation.
In a post-mortem study of 20 patients who died with acute myocardial infarction, plaque
ruptures were found in 60% of lesions with thrombi, while the remainder of 40% only revealed
superficial erosion [16]. Plaque erosion refers to the lack of endothelial cells on the luminal
surface beneath the thrombus. Kramer et al. showed in their study that, when plaque erosion
was the incriminated lesion, the thrombus was limited to the luminal portion of the plaque,
and no ruptures were identified following serial sectioning of these lesions. In the same study,
more than 85% of thrombi in erosions showed evidence of healing, such as acute inflammatory
cell lysis, invasion by smooth muscle cells and/or endothelial cells, or organized layers of
smooth muscle cells and proteoglycans with varying degrees of platelet/fibrin layering. By
contrast, only half of the ruptured plaques showed signs of healing [25].
Beyond histopathological description, a clinically relevant definition of vulnerable plaques
refers to the risk of developing future major cardiac events, which may also involve the
presence of “vulnerable blood” (prone to hypercoagulability) or “vulnerable myocardium”
(susceptible to arrhythmia), either due to acute or pre-existing ischemia and/or non-ischemic
electrophysiological anomalies. The presence of one or more of these elements elevates the
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individual risk of the patients for cardiovascular events, turning them into “vulnerable
patients”.
Identifying vulnerable plaques is currently a major challenge, although recent progress in
cardiovascular imaging raises new possibilities. As vulnerable plaques are prone to rupture
and rapid evolution towards the development of ACS, [26, 27, 28] finding reliable imaging
characteristics that could help detect unstable plaques are of the utmost importance. Early
identification of such plaques could facilitate timely initiation of adequate primary prevention
measures, thus diminishing the incidence of acute coronary events [29]. For this purpose,
several imaging methods have been proposed, including IVUS, optical coherence tomography
(OCT), magnetic resonance imaging (MRI), or MDCT (Table 1), with variable success [30, 31,
32]. However, the use of many of these methods is mainly confined to experimental studies
and has not yet been validated for everyday clinical practice.
Non-invasive imaging methods Advantages Limitations
- MDCT Measures local tissue attenuation to assess
plaque morphology and composition
Molecular imaging using new contrast agents
is under study
Identifies lumen narrowing accurately
Can help characterize plaque morphology
and composition (within limits)
Has high spatial and temporal resolution
Patient exposure to ionizing radiation
Implies contrast agent use
May be hindered by artifacts (e.g.,
blooming)
The attenuation
spectrum of non-calcified plaque
components (lipid and fibrous) can
overlap
- Contrast-enhanced
ultrasonography
Uses acoustically active microbubbles acting
as pure intravascular tracers; when exposed
to ultrasound, they produce a strong
backscatter signal and specific nonlinear
signal that differentiates them from
surrounding tissues
Molecular imaging is available
There is no exposure to ionizing radiation
Has high temporal and spatial resolution
Allows neovasculature assessment
Spatial resolution and penetration are
limited
Good application for coronary arteries
- High-resolution magnetic
resonace imaging
Uses different contrast weightings (T1, T2,
proton-density, and time-of-flight) to
evaluate plaque components
Molecular imaging uses specific agents
(paramagnetic nanoparticles targeting)
Has high temporal and spatial resolution
Has high contrast resolution
Contraindicated with many
intracardiac devices
Cardiac motion
Poor reproducibility
Contrast agent
Limited spatial resolution
Time consuming reconstruction
techniques
Invasive imaging methods
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Non-invasive imaging methods Advantages Limitations
- Coronary angiography Identifies complex plaques, with irregular
surface
Quantifies stenoses accurately
Invasive
Limited tissue penetration and spatial
resolution
- IVUS
Standard Quantifies plaque volume, vascular
remodeling, and neovascularization
Characterizes plaque morphology and
composition
Invasive
Limited temporal resolution
Limited spatial resolution prevents
thin cap fibroatheroma quantification
Low accuracy for detecting plaque
composition by gray scale IVUS
IVUS elastography Measures the local strain rate of vessel wall
and plaque (fibrous plaques are stiffer than
lipid-rich ones); high strain regions describe
more vulnerable plaques
Invasive
Limited spatial resolution
Artefacted by cardiac motion
Virtual histology Identifies the necrotic core, fibro-lipidic
plaques, calcified, and non-calcified plaques
Invasive
Limited spatial resolution
- Optical methods
Angioscopy Identifies lipid plaques, plaque rupture,
erosion, and thrombosis
Invasive
Limited tissue penetration and spatial
resolution
OCT Provides microscopic characterization of
plaque morphology
Identifies macrophages presence
Allows accurate quantification of the fibrous
plaque
Highest spatial resolution of all imaging
methods
Can identify thin fibrous caps <65 µm
The only technique for eroded plaques
detection
Accurate detection of plaque composition
Invasive
Limited tissue penetration; however,
the most relevant morphologic
findings are primarily localized
within the first 500 µm under lumen
surface
Spectroscopy Identifies the lipid core and evaluates the
chemical structure, temperature and
inflammation of the plaque
Invasive
Limited tissue penetration
Cardiac motion
- Termography Quantifies plaque temperature
Detects plaque inflammation and
neoangiogenesis
Invasive
Limited tissue penetration and spatial
resolution
The cooling effect of the blood leads
to underestimated temperature
differences
- Intravascular cardiac MRI Quantifies the lipid content of the plaque Invasive
Prolonged duration
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Non-invasive imaging methods Advantages Limitations
Implies the use of contrast agents
Plasma markers of plaque
vulnerability
Identifies blood hypercoagulability states
(augmented platelet activation and
aggregation, high levels of coagulation
factors, low levels of anticoagulation factors,
decreased endogenous fibrinolytic activity,
thrombogenic factors)
Table 1. Methods for the Identification and Characterization of Vulnerable Plaques
A possible imaging method for coronary artery plaque assessment is IVUS, which has been
used to measure lumen area, plaque burden, and vascular remodeling [33, 34]; plaque burden
and positive remodeling, in particular, can identify high-risk, thin-cap fibroatheromas during
follow-up [34, 35, 36]. As suggested by IVUS-based studies, a vulnerable plaque is character‐
ized by the presence of an extensive necrotic core surrounded by a thin-cap fibrous with
macrophage infiltration, a large lipid pool, and several more specific traits such as positive
remodeling or spotty calcifications [37, 38]. When such characteristics occur, there is an
increased risk of fibrous rupture, exposing the thrombogenic lipid core, which leads to
thrombus formation and the development of ACS. A more detailed analysis of coronary plaque
composition has been provided by virtual histology (VH)-IVUS studies [39, 40, 41].
Another recently developed method for the assessment of coronary artery plaques quantifi‐
cation is intracoronary OCT that provides the advantage of very high resolution (approxi‐
mately 10 to 20 µm), which is about 10-fold higher than that of IVUS [42, 43]. Unlike some
other imaging methods, including CCTA [27, 44, 45], OCT can be used for measuring fibrous
cap thickness and for detecting lipid content, which makes it useful for in vivo identification
of thin-cap fibroatheromas and for evaluating plaque vulnerability [46]. For the time being,
the correspondence between OCT- and IVUS-derived characteristics of thin-cap fibroathero‐
mas, as well as the angiographic stenosis severity, is yet to be established.
As advanced coronary artery plaques have a high level of complexity, basic classifications that
include non-calcified plaques, calcified plaques, and mixed plaques are rather crude and of
limited use for establishing the potential risk for acute ischemic clinical events of individual
lesions [4, 26, 47]. For that reason, some authors have attempted to provide more detailed
descriptions of vulnerable plaques and to establish correlations between CCTA imaging
characteristics (Figure 1) of the lesions and the risk for acute events. Motoyama et al. suggested
that vulnerable plaques are characterized by positive remodeling, low attenuation plaque and
spotty, limited calcification [44]. In later research, non-calcified plaques were more extensively
characterized by modern MDCT and several authors described a ring-like attenuation of the
non-calcified portion of the coronary atherosclerotic lesion, which is now called the napkin-
ring sign [48, 49, 50]. The description of the napkin-ring sign has changed current classifications
of non-calcified plaques, which are now classified in three categories: homogenous plaques,
non-napkin-ring sign heterogeneous plaques, and napkin-ring sign heterogeneous plaques
[49]. The napkin-ring sign corresponds to a morphological type of vulnerable plaque described
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on coronary CCTA (thin-cap fibroatheromas) comprising a necrotic, low attenuation core
surrounded by a thin area of higher attenuation, which some believe may represent the thin
peripheral fibrous cap (Figure 2) [26, 47]. However, in vulnerable plaques, the fibrous cap has
extremely reduced thickness [48, 51], which makes it indistinguishable by non-invasive
imaging methods; by contrast, the necrotic core may be visualized and quantified on thin
sections (<0.6 mm) on modern CCTA [52, 53]. As the presence of the napkin-ring sign was
shown to have a high predictive value for future cardiac events and is considered a valuable
correlate of unstable plaques [49, 27, 20, 54, 55], its detection could add specificity to the CCTA
assessment of vulnerable plaques.
Figure 1. Different Types of Coronary Plaques by CCTA. The 3 main types of coronary plaques are shown: calcified
plaques (A, D), non-calcified plaques (B, E) and partially calcified plaques (C, F), illustrated in curved planar reformat‐
ted and cross-sectional views.
Figure 2. Representative CCTA Images with Napkin-ring Signs. An atherosclerotic plaque with positive remodeling,
low attenuation plaque, and a napkin-ring sign in the proximal left anterior descending artery on computed tomogra‐
phy angiography. The boxed area indicates cross-sectional images of atherosclerotic plaque showing a napkin-ring
sign.
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However, in studies conducted over the last decade, CCTA was also shown to have excellent
sensitivity for detecting, and particularly, for excluding coronary atherosclerosis in patients
with symptoms suggesting either stable or acute CAD [56]. In addition to that, data from large
prospective registries support the use of CAD absence/presence and extension evaluation by
CCTA for prognostic purposes [53, 57, 58, 59, 60]. Recent studies conducted with more
advanced scanners having 64 to 320 detector rows, and higher spatial (230 to 625 µm) and
temporal (75 to 175 ms) resolution focused on identifying vulnerable coronary artery plaques
and on establishing correlation between plaque characteristics and ischemic events [61].
Currently available spatial resolution of CCTA scanners approach the spatial resolution
provided by invasive methods such as IVUS (100 µm) and invasive coronary angiography (200
µm). Moreover, spatial resolution reaching 0.3 mm in-plane in modern CCTA scanners allows
a more accurate discrimination of the non-calcified portion of the plaques [62].
Some researchers [63, 64, 65] attempted to distinguish lipid-rich from fibrous plaque by CCTA
based on attenuation criteria, as expressed by Hounsfield Units (HU), but conflicting results
have been obtained. In addition to that, HU values cannot accurately discriminate between
the types of plaques, mostly due to the small dimensions of the plaque, insufficient spatial
resolution of CCTA, and reduced contrast difference between lipid-rich and fibrous plaques.
In these studies, certified methods of coronary artery plaque quantification (such as IVUS and
histology) were used for comparison to CCTA [63, 64, 65].
Despite current technical limitations, progress has been made in the non-invasive imaging
assessment of coronary artery lesions by CCTA. Data from recent studies suggest that low
attenuation (<30 HU) is more common to culprit lesions in acute coronary events, as well as
to high-risk, vulnerable plaques [26, 27, 47, 66]. Currently, there is not enough data to support
a valid assumption on the accuracy of CCTA for detecting non-calcified coronary plaques at
high risk. Small studies comparing CCTA to IVUS reported sensitivities and specificities
between 80 and 90% for the detection of coronary artery segments with plaque [8, 9, 67, 68].
Other studies demonstrated significant correlations between measurements of plaque cross-
sectional area, volume of single plaques, and plaque volume per coronary segment on CCTA
and IVUS [8, 69, 70, 71]. However, despite significant and quite high correlation coefficients,
the limits of agreement were typically large in most studies, which betrays the limitations of
CCTA, mainly imposed by the spatial resolution of the method. Plaque quantification is
particularly challenging when plaques have low thickness. Reported interobserver variability
is also unusually high (30% variability for plaque volume quantification) [9, 72, 73] and is very
much influenced by image quality. In a research on 41 patients, the interobserver variability
was 17±10% for the left anterior descending coronary artery, which was best, visualized with
fewer artifacts, but escaladed to 29±13% for the left circumflex and 32±10% for the right
coronary artery [73].
2.1.2. Low CT attenuation plaques
In CCTA studies investigating patients with ACS, several features of high-risk plaques have
been described, such as low attenuation plaque, positive remodeling, and spotty calcification
[74, 54]. Recent studies have also described a specific CCTA aspect of coronary artery lesions
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called the napkin-ring sign consisting of a low attenuation area surrounded by a rim-like area
of higher CCTA attenuation [22, 47]. Speculations were made on the histological substrate of
this aspect, as it was believed to be given by either a central lipid core within a fibrous cap,
deep micro-calcifications, neo-vascularization, or the presence of intramural thrombus [22,
27]. Current criteria for the definition of the napkin-ring sign include the presence of a high
attenuation ring around a certain coronary artery plaque and higher CCTA attenuation of the
ring by comparison to the adjacent plaque, but no greater than 130 HU, in order to differentiate
from calcium deposits [27, 47]. Plaques with rich necrotic core have been described as plaques
of low attenuation; low attenuation areas were shown to correlate strongly with echolucent
areas in IVUS [75]. In a large prospective study on more than 1000 patients, low attenuation
plaques and positive remodeling were shown to correlate with the development of acute
coronary events. In this group, 45 patients had both CCTA characteristics and 10 of them (22%)
experienced an acute coronary event vs. only 4 (0.5%) of the patients who did not exhibit
neither positive remodeling nor low attenuation plaques. Patients with normal CCTA did not
have any coronary events at all (p<0.001). In this study, positive remodeling and/or low
attenuation plaques were independent predictors of acute coronary events (hazard ratio: 23,
95% confidence interval: 7 to 75, p<0.001) [74].
A limitation of CCTA in quantifying atherosclerotic plaques may have its origin in the fact that
intravascular attenuation significantly influences the attenuation of the plaques. Cademartiri
et al. performed a phantom test that supports this hypothesis [76, 77] and Schroeder et al. also
obtained similar results in their study [78]. Comparative studies between CCTA density and
IVUS or histopathology suggest that lipid-rich plaques have lower CCTA density than fibrous
plaques. However, low CCTA attenuation is not a constant finding in lipid-rich plaques,
raising controversy over its ability to discriminate between lipid-rich and fibrous plaques. As
mentioned above, some studies have reported that luminal density influences neighboring
structures CCTA attenuation. Some authors reported that, when contrast medium is not used
for examination, significant overlaps can occur between CCTA attenuation values of lipid-rich
and fibrous plaques.
CCTA resolution is defined in terms of spatial, contrast and temporal resolution. Although
significant technological progress has been made in CCTA, the spatial resolution of CCTA (0.5
mm) is still inferior to that of cardiac catheterization or IVUS. The 0.5 resolution is suboptimal,
considering the fact that the average diameter of a coronary artery is 3–4 mm. CCTA density
is influenced by the partial volume effect and contrast resolution has not improved despite
other technological advances in MDCT [27]. CCTA attenuation values, measured in HU, are
given by the amount of radiation absorbed by tissue in the voxel and density is directly
proportional to the attenuation coefficient. A CCTA value of –1,000 HU corresponds to air,
while 0 HU corresponds to water. Most soft tissues CCTA averages have values of 50 HU.
Some tissues, such as bone, calcified tissues, or the iodine-rich tissue of the thyroid gland are
>100 HU, whereas fat or fatty mixed tissue and lung tissue are <0 HU. If the value for a tissue
type, with the exception of calcified or fatty tissues, deviates from the soft tissue attenuation,
artifacts should be considered, particularly if contrast is used and the beam hardening effect
is suspected; another element of confusion may be the presence of a near-by area of calcification
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or fat that may induce a partial volume effect. MIn addition to that, motion artifacts should be
considered. CCTA values can also be influenced by tube voltage [27].
2.1.3. Spotty calcium in plaques
Besides plaque density (Figure 3), other CCTA features such as positive remodeling and spotty
calcification can suggest plaque vulnerability. Positive remodeling is appreciated by referral
to the remodeling index; obviously, expanded plaques have higher remodeling index, above
the cut-off values, but borderline values can hamper interpretation, considering the narrow
lumen of the coronary arteries, which barely averages 4 mm; a difference of 10% is less than 1
pixel on the CCTA image. Consequently, when the set cut-off value is near one, plaque
expansion may be erroneously measured as positive. Also, the presence of spotty calcification
can lead to overestimation of plaque expansion. As the presence of more calcium is considered
to be an element of increased atherosclerotic plaque stability, low calcification plaques are
regarded as more vulnerable [27].
Figure 3. Curved Planar Reformation of the Coronary Artery in CCTA. The curved planar reformatted computed to‐
mography angiography image of the right coronary artery demonstrates two large, predominantly non-calcified athe‐
rosclerotic plaques with spotty calcification (arrowheads) in the proximal segment and mild of the right coronary
artery.
However, pathological studies concluded that calcium is commonly encountered in ruptured
plaques causing sudden cardiac death and that a few scattered small calcium deposits are often
present in the fibrous cap of fibroatheromas [79]. The development of scattered small calcium
around the necrotic core is believed to be triggered by osteogenic changes under the influence
of inflammatory factors and oxidized lipids [80, 81]. The presence of spotty calcifications seems
to induce mechanical instability at the interface with non-calcified plaque components [82].
Clinical studies have shown that: spotty calcification has been associated with an increased
incidence of ischemic cardiovascular events [83] and, more accurately, that patients with ACSs
have a different pattern of calcification when compared to those with stable angina [84]; spotty
calcifications are more likely to be found in culprit lesions in patients with myocardial
infarction than in patients with stable angina [38]; spotty calcification are more commonly
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encountered in patients with accelerated disease progression [85]; ruptured coronary plaques
are associated with spotty calcification, particularly in deep locations and the number of deep
calcium deposits is an independent predictor of culprit plaque ruptures in patients who had
ACSs [84]; and superficial spotty calcifications in IVUS are associated with very late stent
thrombosis after bare-metal stent implantation [86]. A possible caveat in CCTA imaging may
be the fact that microcalcifications under the detection level of CCTA seem to induce very high
plaque instability. However, the presence of calcification increases CCTA values, which seems
to contradict the finding that low attenuation plaques are unstable.
2.2. Plaque quantification
Currently, MDCT with at least 64 detectors allows nearly motion-free visualization of the
coronary arteries and accurate detection of significant stenosis, comparing well to coronary
angiography at low heart rates [8, 87]. Contrast-enhanced scans are performed by injecting
intravenously 80–100 ml of contrast agent at a flow rate of 6 ml/s followed by 70 ml of saline.
The delay time is previously established using the bolus tracking technique with a region of
interest positioned in the ascending aorta; a manually triggered threshold of 100 HU is
specified for the main scanning. All scans are performed during a single breath-hold.
Non-contrast CCTA is also useful for atherosclerotic plaque description, allowing the calcu‐
lation of the coronary artery calcium (CAC) score. The CAC is validated as a good marker of
atherosclerotic burden and high values are associated with increased cardiovascular risk [88],
However, despite relatively easy quantification, the CAC is hindered by several disadvantag‐
es, including the inability to identify small, scattered calcifications in non-calcified plaques,
which may lead to the underestimation of disease severity and cardiovascular risk. Also,
plaque morphology cannot be described on native calcium scans.
Quantitative measurements of coronary plaques aim to assess global atherosclerotic burden
and provide detailed and specific descriptions of plaque morphology that could accurately
evaluate the risk for cardiovascular events [70, 89, 90]. However, volumetric measurements of
coronary artery plaques with manual tracing contours is strenuous and time-consuming;
current software, such as AUTOPLAQ (APQ; Cedars-Sinai Medical Center, Los Angeles, CA),
allow semi-automated quantification of both calcified and non-calcified plaques that has
reduced the examination time and was shown to correlate very well to the IVUS assessment
of the coronary plaque volume
[91]. Dey et al. [92] evaluated the accuracy of APQ and compared semi-automated quantifi‐
cation on CCTA using APQ to IVUS with manual tracing of the coronary artery plaque.
Average examination time was significantly reduced by automated quantification. Manual
IVUS required the longest processing time (15 to 35 minutes), followed by manual CCTA (5
to 15 minutes), while automated plaque segmentation and quantification took less than 20
seconds. There were no significant differences in plaque volumes calculation between IVUS
compared with APQ, or between manual CCTA quantification and APQ. Interestingly, APQ
quantification revealed smaller absolute differences from IVUS results than CT manual
quantification. APQ has also been shown to have reliable interscan reproducibility of quanti‐
tative plaque measurements. Schuhbaeck et al. evaluated total plaque volume, volume of
calcified and non-calcified plaque, and maximal remodeling index by performing CCTAs
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twice in consecutive patients; using APQ there were no significant differences in any of the
measurements between scans [93].
Another CCTA automated software for plaque quantification, QAngio (Medis, Netherland),
has been developed and compared with IVUS. In their study, Boogers et al. [90] evaluated the
accuracy of CCTA automated plaque quantification using a single algorithm to co-register CT
and IVUS after having previously established anatomical markers; slice-by-slice comparisons
of each location along the transverse axis of the coronary arteries have been made. The
compared parameters included the percent lumen area stenosis, plaque burden, the degree of
remodeling at the level of minimal lumen area, and the mean plaque burden for the whole
coronary plaque. The study revealed significant correlations between the two methods
regarding the quantification of lumen area stenosis, plaque burden at the level of the minimal
lumen area, as well as mean plaque burden. However, CCTA failed to quantify all parameters
as accurately as IVUS, underestimating minimal lesion area and overestimating lumen area
stenosis. Moderate correlations were established between the two methods regarding coronary
plaque remodeling. Automated plaque quantification methods are expected to reduce
interobserver variability by comparison with manual quantification techniques. Several
studies were conducted in order to assess the reproducibility of the results. Papadopoulou et
al. [94] reported little inter- and intraobserver variability for lumen and vessel areas. Also, in
an additional study inter- and intraobserver relative differences for lumen, vessel, plaque area,
and plaque burden did not reach statistical significance. Automated plaque quantification
proved, however, less reliable for compositional measurements of plaque attenuation values,
demonstrating high inter-observer variability (12%), which is an important limiting factor.
Despite this drawback, automated softwares can be used for evaluating coronary artery
sclerosis progression, as demonstrated by Papadopoulou et al [95]. In another study, Blackmon
et al. [96] tested the accuracy and interobserver variability for volumetric measurement of non-
calcified lesions of another automated postprocessing software algorithm. Very strong
correlations were found between manual measurements performed by highly experienced
examiners and automated plaque volumetry, and interobserver variability was reduced when
using the plaque analysis algorithm. As demonstrated by the aforementioned studies,
automated softwares provide the major advantage of higher reproducibility, while also
allowing faster quantifications, which make them elligible for more widespread use. CCTA is
very accurate for stenosis detection [97] and for the measurement of calcified plaque burden
[98, 99]. The amount of coronary calcification quantified by CCTA is a strong predictor of CAD
[100, 101], but fails to accurately identify the site of stenosis. Moreover, even in modern CT
scanners, spatial resolution is not sufficient to provide an accurate analysis of the fibrous cap
by CCTA [102]. Also, histopathologically-based studies suggest that vulnerable plaques are
enlarged in all three spatial dimensions [103] and that average measurements of the necrotic
core, such as length and area [104] are beyond the plaque detection threshold for CCTA [105].
2.3. Functional plaque characteristics
Recently, some techniques have been developed for the purpose of analyzing functional
parameters, as well as anatomical structures. CT-based fractional flow reserve (FFR-CT) and
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CT perfusion allow the non-invasive hemodynamic assessment of coronary stenoses and
increase the specificity of CCTA, which may greatly influence the management of CAD
patients in the future [106].
2.3.1. Endothelial Shear Stress (ESS)
ESS refers to the tangential stress that is applied on the endothelial surface of the arterial
wall  by flowing blood friction and is  expressed in units  of  force/unit  area [107].  ESS is
influenced by blood viscosity and the spatial gradient of blood velocity at the wall. When
a fluid passes through a tube, its flow is influenced by the characteristics of the tube walls
such  as  surface  irregularities  or  obstructions.  Fluid  flow  may  be  laminar  or  turbulent.
Laminar flows are streamlined and may be either completely smooth (“undisturbed flows”)
or “disturbed”, with areas of reversed flow. In turbulent flow, velocities vary continuous‐
ly  in  a  certain  point  in  space  [108].  The presence  of  low ESS favors  the  formation and
development of coronary artery plaques, as well as their progression to high-risk, vulnera‐
ble  plaques.  Local  blood  hemodynamics  can  influence  atherosclerosis  development  for
better or for worse. Therefore, an accurate in vivo quantification of plaque characteristics,
local ESS, and vascular remodeling response would facilitate a better understanding of the
mechanisms behind CAD progression, as well as clinical decision making regarding possible
pre-emptive  local  interventions  [109].  The  evolution  of  each  coronary  artery  plaque  is
individual and considerably influenced not only by the progression of atherosclerosis, but
also by vascular remodeling. Extensive remodeling leads to the development of vulnera‐
ble plaques and is triggered by ESS. Persistent ESS favors local lipid build-up, inflamma‐
tion,  oxidative  stress,  and  matrix  breakdown,  with  subsequent  plaque  progression  and
further remodeling [109].  Advanced plaques in areas of severe stenosis are submitted to
considerable shear stress that promotes plaque destabilization [110].
2.3.2. Fractional Flow Reserve (FFR)
FFR is calculated as the ratio between the maximum blood flow within a diseased coronay
artery and the theoretical  maximum flow in a normal coronary artery.  An FFR of 1.0 is
considered  normal,  while  values  of  less  than  0.75–0.80  are  acknowledged  by  most  as
associated with myocardial ischemia [111]. FFR values >0.8 but <1 are considered indica‐
tive  of  a  hemodinamically  unsignificant  stenosis,  while  values  <0.75  reflect  significant
stenoses.  In  earlier  works,  values  between  0.75–0.80  represented  a  grey  area  and  were
interpreted according to the clinical context. Investigators estimated that the cut-off value
for  FFR  could  be  extended  to  0.80,  thus  improving  sensitivity  without  significantly
compromising specificity. The cut-off value of 0.80 was already used in the FAME 1 and
FAME 2 trials and proved to be clinically valid [112, 113]. This is now the recommended
ischemic  reference  standard  for  the  invasive  assessment  of  myocardial  ischemia  [114].
Invasive  coronary  angiography  is  the  established  clinical  standard  for  coronary  artery
disease  assessment,  with  IVUS  providing  the  advantage  of  intramural  and  transmural
coronary artery imaging. OCT offers an even more accurate visualization of the coronary
arteries [115]. The use of these additional invasive imaging methods can facilitate therapeut‐
ical decisions regarding revascularization and help guide percutaneous coronary interven‐
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tions,  leading to  better  postprocedural  results.  However,  in  current  clinical  practice,  the
reported  rates  of  use  for  these  techniques  in  assessing  intermediate  (40–70%)  coronary
stenoses are fairly low, 20.3% for IVUS and 6.1% for FFR [116].
In the Percutaneous Coronary Intervention of Functionally Non-significant Stenosis (DEFER)
Study [117], investigators evaluated 181 patients with stable ischemic heart disease and FFR >
0.75 across an intermediate stenosis. These patients were randomized to either percutaneous
coronary interventions or to deferral of percutaneous coronary interventions with medical
treatment. At 5-year follow-up, patients in the deferred group had a significantly decreased
(less than half) rate of death or myocardial infarction by comparison with the percutaneous
coronary interventions group. In the Fractional Flow Reserve versus Angiography for
Multivessel Evaluation (FAME) trial [113], 1,005 patients with multivessel disease were
randomized to either FFR- or angiography-guided percutaneous coronary interventions. In
patients with FFR-guided interventions, the composite rate of death, MI, or repeated revas‐
cularization at 1 year was significantly lower (13.2% vs. 18.3%, P<0.02). The Fractional Flow
Reserve versus Angiography for Multivessel Evaluation 2 (FAME 2) trial [113] compared the
outcomes of FFR-guided percutaneous coronary interventions with optimal medical therapy
against optimal medical therapy alone in a group of 888 patients with stable ischemic heart
disease. In this trial, unlike in others such as COURAGE, only patients having at least one
lesion with FFR <0.80 were enrolled [118].
FFR assessment of lesions with 50% to 70% diameter narrowing revealed that only 35% of
the lesions were hemodynamically significant. Interestingly, in severe lesions with 71% to
90% diameter stenoses, 20% were not hemodynamically significant based on FFR and did
not require percutaneous coronary interventions. These results endorse the hypothesis that
FFR can have essential clinical implications regarding revascularization decisions even in
more severe angiographic stenoses and, particularly when noninvasive data is discordant
with coronary angiography [119]. In patients with multivessel coronary artery disease, FFR
can be performed, allowing an accurate determination of the Functional SYNTAX Score,
and  subsequently,  a  better  selection  of  patients  that  could  benefit  from  percutaneous
coronary intervention rather than being submitted to coronary artery by-pass graft [120].
The use of CCTA for non-invasive anatomic assessment has increased considerably and the
method is considered an accurate tool for detecting or excluding CAD [6, 5]. FFR-CT is a
recently developed method based on computational fluid dynamics to calculate coronary
blood flow, pressure, and FFR based on routinely acquired CCTA datasets [121, 122, 123,
124, 125, 126, 127, 128, 129].
3. Clinical implications of napkin-ring sign plaque for prognosis and
management
Recent research has shown that the napkin-ring sign is associated with future cardiac events,
frequently corresponding to the culprit lesion in ACS [53]. In the study by Otsuka et al.,
895 patients were evaluated by CCTA and followed up for 2.3±0.8 years; in this popula‐
Coronary CT Angiography and the Napkin-ring Sign Indicates High-Risk Atherosclerotic Lesions
http://dx.doi.org/10.5772/61393
127
tion,  the  presence  of  the  napkin-ring  sign  on  CCTA was  strongly  associated  with  ACS
events: 24 patients (2.6%) experienced ACS events, of which 41% developed plaques with
napkin-ring sign during the follow-up period [53].  Kashiwagi et  al.  conducted a CCTA-
based study on 273 patients with either ACS or stable angina. In their research, the authors
described the napkin-ring sign as the presence of a ring of high attenuation and the CT
attenuation of a ring presenting higher than those of the adjacent plaque and no greater
than 130  HU.  The  napkin-ring  sign was  more  frequently  encountered in  culprit  lesions
(12.7% vs. 2.8%, p<0.01). Moreover, napkin-ring sign plaques were associated with a higher
remodeling index and lower CT attenuation (1.15 ± 0.12 vs. 1.02 ± 0.12, p<0.01 and 39.9 ±
22.8 HU vs.72.7 ± 26.6 HU, p<0.01) [50]. Similar results were obtained in another study in
which the napkin-ring sign was more common in patients developing ACS than in those
with stable angina [28].
Besides the napkin-ring sign, other imaging characteristics such as large plaque volume,
low  CT  attenuation,  positive  remodeling,  and  spotty  calcification  were  proved  to  be
correlated with a higher risk of  acute events [130].  Motoyama et  al.  found that  positive
remodeling and low attenuation correlated best with the development of ACS, [74] which
is  consistent  with  results  from  other  studies  [131,  132].  Considering  the  results  of  the
previously mentioned studies,  one can conclude that  the identification of  CCTA aspects
suggesting vulnerable lesions may be useful for several reasons. Firstly,  although statins
are known to reduce the incidence of acute cardiovascular events [133], proving their effect
on a  certain  individual  is  challenging.  CCTA may help  identify  coronary artery  lesions
regression, but, as it is not routinely performed, there is not enough data to support this
hypothesis. Risk stratification in asymptomatic individuals has also been taken into account
as  a  possible  use  for  CCTA,  but  the  actual  ability  of  MDCT  for  detecting  small  non-
stenotic plaques is yet to be established [134].
In conclusion CCTA is used extensively nowadays as a non-invasive imaging method for
the evaluation of patients suspected of CAD and the napkin-ring sign described on CCTA
has been designated as a valid element for identifying vulnerable plaques, indicating an
increased probability of rupture,  and was shown to correlate with a higher incidence of
cardiovascular events.
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